NCT02986659View on ClinicalTrials.gov

Genomic Outcomes of Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 3, 2016

Primary Completion Date

November 15, 2018

Study Completion Date

November 15, 2018

Conditions
Coronary Artery DiseaseMild Cognitive ImpairmentObesity, AbdominalHypertension
Interventions
DRUG

Metformin

DRUG

Placebo

Trial Locations (1)

27157

Wake Forest Health Sciences, Winston-Salem

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT02986659 - Genomic Outcomes of Metformin | Biotech Hunter | Biotech Hunter